BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 33410215)

  • 21. Identification of two new HLA-A*1101-restricted tax epitopes recognized by cytotoxic T lymphocytes in an adult T-cell leukemia patient after hematopoietic stem cell transplantation.
    Harashima N; Tanosaki R; Shimizu Y; Kurihara K; Masuda T; Okamura J; Kannagi M
    J Virol; 2005 Aug; 79(15):10088-92. PubMed ID: 16014972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a Unique T Cell Receptor Gene-Transferred Tax-Redirected T Cell Immunotherapy for Adult T Cell Leukemia.
    Kawamura K; Tanaka Y; Nakasone H; Ishihara Y; Kako S; Kobayashi S; Tanaka Y; Ohmori T; Uchimaru K; Okamoto S; Mineno J; Shiku H; Nishimura S; Kanda Y
    Biol Blood Marrow Transplant; 2020 Aug; 26(8):1377-1385. PubMed ID: 32311478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells.
    Kannagi M; Harada S; Maruyama I; Inoko H; Igarashi H; Kuwashima G; Sato S; Morita M; Kidokoro M; Sugimoto M
    Int Immunol; 1991 Aug; 3(8):761-7. PubMed ID: 1911545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential contribution of a novel Tax epitope-specific CD4+ T cells to graft-versus-Tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantation.
    Tamai Y; Hasegawa A; Takamori A; Sasada A; Tanosaki R; Choi I; Utsunomiya A; Maeda Y; Yamano Y; Eto T; Koh KR; Nakamae H; Suehiro Y; Kato K; Takemoto S; Okamura J; Uike N; Kannagi M
    J Immunol; 2013 Apr; 190(8):4382-92. PubMed ID: 23475215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic T cell response and expression of the target antigen in HTLV-I infection.
    Kannagi M; Matsushita S; Shida H; Harada S
    Leukemia; 1994 Apr; 8 Suppl 1():S54-9. PubMed ID: 8152305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Among all human T-cell leukemia virus type 1 proteins, tax, polymerase, and envelope proteins are predicted as preferential targets for the HLA-A2-restricted cytotoxic T-cell response.
    Pique C; Connan F; Levilain JP; Choppin J; Dokhélar MC
    J Virol; 1996 Aug; 70(8):4919-26. PubMed ID: 8763995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes.
    Yashiki S; Fujiyoshi T; Arima N; Osame M; Yoshinaga M; Nagata Y; Tara M; Nomura K; Utsunomiya A; Hanada S; Tajima K; Sonoda S
    AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1047-61. PubMed ID: 11485622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.
    Kozako T; Fukada K; Hirata S; White Y; Harao M; Nishimura Y; Kino Y; Soeda S; Shimeno H; Lemonnier F; Sonoda S; Arima N
    Mol Immunol; 2009 Dec; 47(2-3):606-13. PubMed ID: 19889459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination with short-term-cultured autologous PBMCs efficiently activated STLV-1-specific CTLs in naturally STLV-1-infected Japanese monkeys with impaired CTL responses.
    Hasegawa A; Murata M; Fujikawa T; Katagiri K; Nagano Y; Masuda T; Kuramitsu M; Nakajima S; Fujisawa JI; Okuma K; Grover P; Kidiga M; Akari H; Kannagi M
    PLoS Pathog; 2023 Feb; 19(2):e1011104. PubMed ID: 36730466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HTLV-1 Tax-Specific CTL Epitope-Pulsed Dendritic Cell Therapy Reduces Proviral Load in Infected Rats with Immune Tolerance against Tax.
    Ando S; Hasegawa A; Murakami Y; Zeng N; Takatsuka N; Maeda Y; Masuda T; Suehiro Y; Kannagi M
    J Immunol; 2017 Feb; 198(3):1210-1219. PubMed ID: 28011931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages.
    Shimizu Y; Takamori A; Utsunomiya A; Kurimura M; Yamano Y; Hishizawa M; Hasegawa A; Kondo F; Kurihara K; Harashima N; Watanabe T; Okamura J; Masuda T; Kannagi M
    Cancer Sci; 2009 Mar; 100(3):481-9. PubMed ID: 19154412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the target antigen for cytotoxic T lymphocytes on adult T-cell-leukemia cells.
    Kannagi M; Matsushita S; Harada S
    Int J Cancer; 1993 Jun; 54(4):582-8. PubMed ID: 8514449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation and detection of HTLV-I Tax-specific CTLs by epitope expressing single-chain trimers of MHC class I in a rat model.
    Ohashi T; Nagai M; Okada H; Takayanagi R; Shida H
    Retrovirology; 2008 Oct; 5():90. PubMed ID: 18840303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Development of Tax-redirected T-cell immunotherapy using TCR gene transduction in patients with ATL].
    Tanaka Y; Kanda Y
    Rinsho Ketsueki; 2015 Jul; 56(7):815-24. PubMed ID: 26251144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oligomannose-coated liposomes efficiently induce human T-cell leukemia virus-1-specific cytotoxic T lymphocytes without adjuvant.
    Kozako T; Hirata S; Shimizu Y; Satoh Y; Yoshimitsu M; White Y; Lemonnier F; Shimeno H; Soeda S; Arima N
    FEBS J; 2011 Apr; 278(8):1358-66. PubMed ID: 21332943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease.
    Koenig S; Woods RM; Brewah YA; Newell AJ; Jones GM; Boone E; Adelsberger JW; Baseler MW; Robinson SM; Jacobson S
    J Immunol; 1993 Oct; 151(7):3874-83. PubMed ID: 7690819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis.
    Parker CE; Daenke S; Nightingale S; Bangham CR
    Virology; 1992 Jun; 188(2):628-36. PubMed ID: 1374983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential immunogenicity of adult T cell leukemia cells in vivo.
    Kurihara K; Harashima N; Hanabuchi S; Masuda M; Utsunomiya A; Tanosaki R; Tomonaga M; Ohashi T; Hasegawa A; Masuda T; Okamura J; Tanaka Y; Kannagi M
    Int J Cancer; 2005 Mar; 114(2):257-67. PubMed ID: 15551352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-tumor immunity in adult T-cell leukemia].
    Kannagi M
    Uirusu; 2004 Jun; 54(1):67-74. PubMed ID: 15449906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New treatment strategy for adult T-cell leukemia targeting for anti-tumor immunity and a longevity gene-encoded protein].
    Kozako T
    Yakugaku Zasshi; 2011; 131(7):1061-72. PubMed ID: 21720136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.